Navigation Links
CardioMEMS Vice President - Information Systems, Richard Powers, and Chairman of the Board, John Huntz, Selected as Finalists for Prestigious Awards
Date:4/30/2013

ATLANTA, April 30, 2013 /PRNewswire/ -- CardioMEMS, Inc., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, announced today that the Company's Vice President of Information Systems, Richard Powers , has been named a finalist for the 2013 Georgia CIO of the Year Award® in the Corporate category.  The awards, presented in affiliation with the Georgia CIO Leadership Association, recognize CIOs who have contributed to their company's growth and business, as well as have been activity evolved in their community.  The 2013 Georgia CIO of the Year Awards will be presented at a breakfast gala on Friday, November 1 at the Cobb Galleria Center. More information on the 2013 CIO of the Year Awards can be found at http://www.georgiacio.org/finalists/about-the-event.html.

In other news, John Huntz , Chairman of the Board for CardioMEMS and Manhattan Associates and the Executive Director of Arcapita Ventures, was honored at the TiECon Southeast Conference and Gala on April 27, as a finalist for the Venture Capitalist of the Year Award.  Mr. Huntz, the founder of the Southern Capital Forum, has served as a Board Member for a number of start-up and growth stage companies, including CardioMEMS, and has invested over $100 million in southeastern technology-based companies over the course of his career. 

About CardioMEMS, Inc.
CardioMEMS is a medical device company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body. The company's technology platform is designed to improve the management of severe chronic cardiovascular diseases such as aneurysms, heart failure, and hypertension. CardioMEMS miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data, which are critical to the management of patients. The sensors are designed to be permanently implanted into the heart and blood vessels due to their small size, durability and lack of wires and batteries. Using radiofrequency (RF) energy, the sensors transmit real-time data to external electronic readers, which then communicate this information to the patient's physician. CardioMEMS developed this technology based on the belief that frequent, on-demand, real-time monitoring of vital information enables proactive patient management, which holds the promise of reducing hospitalizations, improving a patient's quality of life and delivering more efficient and cost effective health care. More information about CardioMEMS is located at www.cardiomems.com.

Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company's products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.

CardioMEMS and the CardioMEMS logo are registered trademarks of CardioMEMS, Inc. Champion is a trademark of CardioMEMS, Inc.

Caution: The Champion Heart Failure Monitoring System is an investigational device limited by federal law to investigational use.


'/>"/>
SOURCE CardioMEMS, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CardioMEMS, Inc. wins 2012 Intel Innovation Award
2. CardioMEMS Named as a Finalist for Intel Innovation Award
3. Metamark Genetics Board of Directors Appoints Shawn M. Marcell President and Chief Executive Officer
4. Afraxis Appoints Carmine Stengone President and Chief Executive Officer, and Christopher Rex, Ph.D., Chief Scientific Officer
5. Comprehensive Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.
6. Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.
7. Sense4Baby, Inc. Names Dr. Jessica Grossman President and CEO
8. Aethlon Medical (AEMD) Note: New Government Contract, Resubmission of IDE to Treat Hepatitis C (HCV), Biothreat Legislation Signed into Law by President Obama
9. Hospira Names Matthew R. Stober Senior Vice President of Operations
10. Joint Statement On The Presidents Budget From The American Society Of Clinical Oncology, Community Oncology Alliance, ION Solutions and The US Oncology Network
11. MedeAnalytics Selects Ping Zhang as Senior Vice President of Product Innovation and Chief Technology Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 2017  SARES•REGIS Group leased the first of ... Conejo Spectrum Business Park in Thousand ... Inc. , a biopharmaceutical company developing meaningful therapies ... have been underserved by scientific innovation, with an ... autoimmune and infectious disease. Before commencement ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
(Date:4/18/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 6.35% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... 26, 2017 , ... Journal of Oral Implantology – Tooth loss ... overall dental health, including complications with speech, eating, and overcompensation of mouth due to ... lost teeth. As the number of tooth replacements increase, it is imperative to design ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... in Hackensack, N.J. has been honored by Enterprising Women magazine as one ... recognizes the world’s top women business owners. Winners have demonstrated that they have ...
(Date:4/26/2017)... , ... April 26, 2017 , ... RawTrition now brings ... way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients to ... cellular level because the body recognizes its raw form (unlike the synthetically made options ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a medical ... that it has received 510(k) clearance from the U.S. Food & Drug Administration ... Pro. , Both devices are stationary cycling systems that use MYOLYN’s patent-pending ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor ... I/II HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded ...
Breaking Medicine News(10 mins):